CRYGS

crystallin gamma S

Summary

Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. Since lens central fiber cells lose their nuclei during development, these crystallins are made and then retained throughout life, making them extremely stable proteins. Mammalian lens crystallins are divided into alpha, beta, and gamma families; beta and gamma crystallins are also considered as a superfamily. Alpha and beta families are further divided into acidic and basic groups. Seven protein regions exist in crystallins: four homologous motifs, a connecting peptide, and N- and C-terminal extensions. Gamma-crystallins are a homogeneous group of highly symmetrical, monomeric proteins typically lacking connecting peptides and terminal extensions. They are differentially regulated after early development. This gene encodes a protein initially considered to be a beta-crystallin but the encoded protein is monomeric and has greater sequence similarity to other gamma-crystallins. This gene encodes the most significant gamma-crystallin in adult eye lens tissue. Whether due to aging or mutations in specific genes, gamma-crystallins have been involved in cataract formation. [provided by RefSeq, Jul 2008]

Known Variants47 total

rsidPosition (GRCh37)AllelesClassClinVar
rs7477873003:186,256,501C/T—uncertain significance
rs7695077003:186,256,502G/A—uncertain significance
rs13891613653:186,256,520G/A—uncertain significance
rs24745009843:186,256,572G/T—uncertain significance
rs9151169533:186,256,586G/A—uncertain significance
rs9678760423:186,256,601C/A—uncertain significance
rs7807134003:186,256,636G/A—uncertain significance
rs5709667533:186,256,648C/T—uncertain significance
rs2016422913:186,256,667T/G—uncertain significance
rs17139895033:186,256,670T/C—uncertain significance
rs3766532753:186,256,686G/A—likely benign
rs1141862693:186,256,716C/T—likely benign
rs1441246713:186,256,717C/T—likely benign
rs3756325983:186,256,723T/G—uncertain significance
rs1404218413:186,256,728G/T—benign
rs12752393793:186,256,753C/G—uncertain significance
rs3676801733:186,256,769C/T—likely benign
rs738879433:186,256,880C/T—benign
rs1504419053:186,256,961C/T—likely benign
rs1162127983:186,257,040C/T—likely benign
rs15538469263:186,257,155C/T—uncertain significance
rs17140024343:186,257,160C/T—uncertain significance
rs17140025053:186,257,161A/G—uncertain significance
rs7649691893:186,257,172C/T—uncertain significance
rs7616281473:186,257,184C/T—uncertain significance
rs1448125373:186,257,193C/T—conflicting classifications of pathogenicity
rs7502368063:186,257,194G/A—uncertain significance
rs7582374943:186,257,205G/A—uncertain significance
rs24745019963:186,257,209A/T—likely pathogenic
rs24745020713:186,257,269A/G—uncertain significance
rs15789566893:186,257,284C/T—pathogenic
rs11843982433:186,257,292G/C—likely pathogenic
rs7647937753:186,257,301C/T—uncertain significance
rs1435078273:186,257,331T/C—conflicting classifications of pathogenicity
rs10356141133:186,257,346T/C—uncertain significance
rs617437143:186,257,353G/A—uncertain significance
rs1048937363:186,257,355C/Amissense variantpathogenic
rs1479710153:186,257,369G/T—conflicting classifications of pathogenicity
rs1434240003:186,257,376T/C—uncertain significance
rs1130318383:186,257,384A/T—benign
rs21087436413:186,257,385A/T—likely pathogenic
rs730553903:186,257,683G/C—benign
rs1489396613:186,261,443G/Adownstream gene variant—
rs730553983:186,262,041G/T—benign
rs168608833:186,262,063C/T—likely benign
rs12614879213:186,262,089A/G—uncertain significance
rs786893523:186,262,497G/A—benign

Gene information from NCBI Gene. Variant classifications from ClinVar.